FMC (FMC) Q2 2026 Earnings Call Transcript
FMC Corp. held its Q2 2026 earnings call. It reported Q1 revenue of $762 million, down 4% year over year, and adjusted EBITDA of $72 million. Full-year guidance calls for revenue of $3.6 billion to $3.8 billion and adjusted EBITDA of $670 million to $730 million. The company targets $1 billion debt reduction in 2026 via an India business sale and other disposals.
How this was made
The 30-second read
Why it matters
Traders can update models for 2026 profitability, interest expense, and free cash flow, and reassess near-term liquidity risk tied to debt reduction funding sources and refinancing plans.
Market read
The call is a guidance and balance-sheet update: lower full-year EBITDA and EPS, higher interest expense, negative Q1 free cash flow, and a $1B 2026 debt reduction target dependent on India asset sale and financing.
What to watch
Execution risk is concentrated in the India commercial business definitive agreement timing and the planned secured high-yield bond offering to redeem $500M notes, which could swing leverage and liquidity expectations.
Background
This is FMC’s Q2 2026 earnings call transcript covering Q1 results, full-year guidance, leverage covenant updates, and strategic actions including India divestiture and new active ingredient commercialization.
Ticker impact
FMC guided full-year revenue $3.6B to $3.8B and adjusted EBITDA $670M to $730M, citing pricing declines and currency headwinds.
Near-term bias likely negative to neutral on leverage and FCF concerns, with upside sensitivity to debt-reduction execution and Brazil order momentum.
The call discloses multiple forward-looking datapoints: lower EBITDA and EPS, higher interest expense, negative Q1 FCF, and a $1B 2026 debt reduction target funded by India divestiture and asset sales. Offsetting positives include new active ingredient growth and Brazil direct sales order commitments, but the net effect is still a deleveraging story with near-term cash risk.
Market effects
Ag chemicals investors may reprice pesticide pricing power and generic substitution risk, especially around patent-expired insecticide classes like Rynaxypyr.
Brazil direct sales order momentum and currency tailwind/headwind assumptions can influence regional demand expectations and FX sensitivity for ag names.
Geopolitical and trade-action cost pass-through commentary (energy, transportation, petrochemicals) highlights global input-cost volatility risk for the crop-protection supply chain.
Counterpoint
The guidance could be conservative; if restructuring cash spending and debt refinancing proceed smoothly, the market may focus more on balance-sheet progress than on near-term FCF negativity.
Key entities
- companyFMC Corporation
Provides Q1 results and 2026 guidance, including revenue, adjusted EBITDA, adjusted EPS, leverage covenants, and debt reduction plan via India divestiture and financing.
- executivePierre Brondeau
CEO who discussed cost pressures, generic substitution dynamics, and expectations for active ingredient growth and EU planted hectares access.
- executiveAndrew Sandifer
CFO who discussed leverage covenant structure and secured credit facility collateral package.
